Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-05

Clinical Trial Update: A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors

View source ↗

Summary

This clinical trial update reports completion of a study to determine whether there is an association between nonarteritic anterior ischemic optic neuropathy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PDE5 inhibitor

Snippet

Sponsor: Eli Lilly and Company | Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy | Status: COMPLETED | Results posted: 2018-04-05